{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:19:53Z","timestamp":1793387993269,"version":"4.5.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>The gut-brain axis is emerging as a key player in Parkinson's disease (PD), with growing attention on how the gut microbiome (GM) shapes microglial activity, a central driver of neuroinflammation and dopaminergic loss. GM dysbiosis, characterized by reduced beneficial microbes and increased proinflammatory taxa, can compromise intestinal barrier integrity, activate systemic immunity, and prime microglia toward a proinflammatory state, potentially facilitating \u03b1-synuclein misfolding and propagation from gut to brain. Preclinical studies reveal that probiotics can rebalance microbial communities, enhance short-chain fatty acid production, reinforce intestinal barrier integrity, and modulate immune responses, effects collectively linked to reduced microglial reactivity, lower \u03b1-synuclein aggregation, and improved motor outcomes in PD models. Human trials of probiotic supplementation in PD, primarily investigating gastrointestinal and non-motor symptoms, suggest potential benefits for systemic inflammation and neuroimmune signaling, though direct evidence of central microglial modulation is limited. By synthesizing animal and clinical data, this review underscores both the therapeutic promise of probiotics and identifies current gaps in leveraging microbiota-based interventions as non-invasive, disease-modifying strategies for PD.<\/jats:p>","DOI":"10.3389\/fnmol.2025.1690507","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:27:48Z","timestamp":1759987668000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Food for thought: probiotic modulation of microglial activity in Parkinson's disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Isabella","family":"Kroker Kimber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-\u00c8ve","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1084\/jem.20180794","article-title":"Microbiome\u2013microglia connections via the gut-brain axis","volume":"216","author":"Abdel-Haq","year":"2019","journal-title":"J. Exp. Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e81453","DOI":"10.7554\/eLife.81453.sa2","article-title":"A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice","volume":"11","author":"Abdel-Haq","year":"2022","journal-title":"Elife"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.3390\/app12094680","article-title":"The effect of probiotics on intestinal tight junction protein expression in animal models: a meta-analysis","volume":"12","author":"Ahn","year":"2022","journal-title":"Appl. Sci. Switz"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1330903","DOI":"10.3389\/fnut.2024.1330903","article-title":"Approach to the diagnosis and management of dysbiosis","volume":"11","author":"Alagiakrishnan","year":"2024","journal-title":"Front. Nutr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1496616","DOI":"10.3389\/fnut.2024.1496616","article-title":"Microbiome-based therapies for Parkinson's disease","volume":"11","author":"Alam","year":"2024","journal-title":"Front. Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/cells8101293","article-title":"What do microglia really do in healthy adult brain?","volume":"8","author":"Augusto-Oliveira","year":"2019","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.08.007","article-title":"The blood-brain barrier in neuroimmunology: tales of separation and assimilation","volume":"44","author":"Banks","year":"2015","journal-title":"Brain. Behav. Immun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/acschemneuro.8b00733","article-title":"Lipopolysaccharide from gut microbiota modulates \u03b1-synuclein aggregation and alters its biological function","volume":"10","author":"Bhattacharyya","year":"2019","journal-title":"ACS Chem. Neurosci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1152\/ajpgi.00338.2016","article-title":"Irritable bowel syndrome: a gut microbiota-related disorder?","volume":"312","author":"Bhattarai","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/microorganisms11061527","article-title":"Therapeutic prospect of new probiotics in neurodegenerative diseases","volume":"11","author":"Bi","year":"2023","journal-title":"Microorganisms"},{"key":"B14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/phar.2731","article-title":"Gut microbiome health and dysbiosis: a clinical primer","volume":"42","author":"Bidell","year":"2022","journal-title":"Pharmacotherapy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.29300","article-title":"Integrated multi-cohort analysis of the Parkinson's disease gut metagenome","volume":"38","author":"Boktor","year":"2023","journal-title":"Mov. Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10020375","article-title":"Alpha-synuclein: mechanisms of release and pathology progression in synucleinopathies","volume":"10","author":"Br\u00e1s","year":"2021","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","article-title":"Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve","volume":"108","author":"Bravo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41598-022-27086-x","article-title":"Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids","volume":"13","author":"Caetano-Silva","year":"2023","journal-title":"Sci. Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12974-025-03454-y","article-title":"Elucidating the specific mechanisms of the gut-brain axis: the short-chain fatty acids-microglia pathway","volume":"22","author":"Cao","year":"2025","journal-title":"J. Neuroinflamm."},{"key":"B21","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1177\/1877718X251328567","article-title":"Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation","volume":"15","author":"Chai","year":"2025","journal-title":"J. Park. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12929-022-00839-6","article-title":"Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis","volume":"29","author":"Chen","year":"2022","journal-title":"J. Biomed. Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"617370","DOI":"10.3389\/fnagi.2021.617370","article-title":"Evidence for peripheral immune activation in Parkinson's disease","volume":"13","author":"Chen","year":"2021","journal-title":"Front. Aging Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.arr.2022.101812","article-title":"Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis","volume":"84","author":"Claudino dos Santos","year":"2023","journal-title":"Ageing Res. Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1011129","DOI":"10.3389\/fimmu.2022.1011129","article-title":"Microglial cells: sensors for neuronal activity and microbiota-derived molecules","volume":"13","author":"D'Alessandro","year":"2022","journal-title":"Front. Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota\u2013gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17879\/freeneuropathology-2020-2920","article-title":"Enteric synucleinopathy: from trendy concept to real entity","volume":"1","author":"de Lataillade","year":"2020","journal-title":"Free Neuropathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern. Emerg. Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.siny.2016.04.012","article-title":"Fetal, neonatal, and infant microbiome: perturbations and subsequent effects on brain development and behavior. Semin","volume":"21","author":"Diaz Heijtz","year":"2016","journal-title":"Fetal. Neonatal Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","article-title":"The gut-brain axis: two ways signaling in Parkinson's disease","volume":"42","author":"Dogra","year":"2021","journal-title":"Cell. Mol. Neurobiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/s41467-017-01973-8","article-title":"Meta-analysis of gut microbiome studies identifies disease-specific and shared responses","volume":"8","author":"Duvallet","year":"2017","journal-title":"Nat. Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.4103\/1673-5374.391191","article-title":"Gut microbiota dysbiosis contributes to \u03b1-synuclein-related pathology associated with C\/EBP\u03b2\/AEP signaling activation in a mouse model of Parkinson's disease","volume":"19","author":"Fang","year":"2024","journal-title":"Neural Regen. Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1305933","DOI":"10.3389\/fimmu.2023.1305933","article-title":"Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression","volume":"14","author":"Fornari Laurindo","year":"2023","journal-title":"Front. Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101973","DOI":"10.1016\/j.pneurobio.2020.101973","article-title":"Astrocytes and microglia in neurodegenerative diseases: lessons from human in vitro models","volume":"200","author":"Franklin","year":"2021","journal-title":"Prog. Neurobiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous systems in health and disease","volume":"20","author":"Fung","year":"2017","journal-title":"Nat. Neurosci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fncel.2018.00398","article-title":"Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson's disease","volume":"12","author":"Garc\u00eda-Dom\u00ednguez","year":"2018","journal-title":"Front. Cell. Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"eabq2923","DOI":"10.1126\/sciadv.abq2923","article-title":"Mapping microglia and astrocyte activation in vivo using diffusion MRI","volume":"8","author":"Garcia-Hernandez","year":"2022","journal-title":"Sci. Adv"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4784268","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in parkinson's disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.3390\/ijms26083532","article-title":"Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction. Int. J. Mol","volume":"26","author":"Gryka-Marton","year":"2025","journal-title":"Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pharmthera.2018.09.003","article-title":"TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward","volume":"194","author":"Guilarte","year":"2019","journal-title":"Pharmacol. Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00702-017-1792-x","article-title":"Let's make microglia great again in neurodegenerative disorders","volume":"125","author":"Guillot-Sestier","year":"2018","journal-title":"J. Neural Transm"},{"key":"B46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"848344","DOI":"10.3389\/fmed.2022.848344","article-title":"The role and function of mucins and its relationship to inflammatory bowel disease","volume":"9","author":"Kang","year":"2022","journal-title":"Front. Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3390\/microorganisms12112333","article-title":"Unraveling the role of the human gut microbiome in health and diseases","volume":"12","author":"Khalil","year":"2024","journal-title":"Microorganisms"},{"key":"B49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"B50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. Parkinsonism Relat","volume":"82","author":"Lavisse","year":"2021","journal-title":"Disord"},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2021.07.026","article-title":"Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: a systematic review of preclinical and clinical evidence","volume":"98","author":"Leta","year":"2021","journal-title":"Brain. Behav. Immun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"Liu","year":"2017"},{"key":"B53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-016-0307-y","article-title":"The healthy human microbiome","volume":"8","author":"Lloyd-Price","year":"2016","journal-title":"Genome Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota\u2013gut-brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11030433","article-title":"New avenues for parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota","volume":"11","author":"Lorente-pic\u00f3n","year":"2021","journal-title":"Biomolecules"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/brainsci14111147","article-title":"The impact of probiotics on clinical symptoms and peripheral cytokines levels in Parkinson's disease: preliminary in vivo data","volume":"14","author":"Magistrelli","year":"2024","journal-title":"Brain Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1446700","DOI":"10.3389\/fnins.2024.1446700","article-title":"Roles of the gut microbiota in human neurodevelopment and adult brain disorders","volume":"18","author":"Mallick","year":"2024","journal-title":"Front. Neurosci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","article-title":"Microglia heterogeneity in the single-cell era","volume":"30","author":"Masuda","year":"2020","journal-title":"Cell Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mdc3.70029","article-title":"The gut-brain axis in Parkinson disease: emerging concepts and therapeutic implications","volume":"12","author":"Menozzi","year":"2025","journal-title":"Mov. Disord. Clin. Pract"},{"key":"B60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota\u2013brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1007\/s00253-023-12789-6","article-title":"The link between the gut microbiome, inflammation, and Parkinson's disease","volume":"107","author":"Nie","year":"2023","journal-title":"Appl. Microbiol. Biotechnol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41522-022-00367-z","article-title":"Inflammatory microbes and genes as potential biomarkers of Parkinson's disease","volume":"8","author":"Nie","year":"2022","journal-title":"Npj Biofilms Microbiomes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav","volume":"277","author":"O'Mahony","year":"2015","journal-title":"Brain Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries\/territories from 1990 to 2019","volume":"9","author":"Ou","year":"2021","journal-title":"Front. Public Health"},{"key":"B65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12640-022-00627-y","article-title":"Neuroprotective and immunomodulatory effects of probiotics in a rat model of Parkinson's disease. Neurotox","volume":"41","author":"Parra","year":"2023","journal-title":"Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4103\/aian.aian_460_23","article-title":"Dysbiosis of the Beneficial gut bacteria in patients with Parkinson's disease from india","volume":"26","author":"Pavan","year":"2023","journal-title":"Ann. Indian Acad. Neurol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1225120","article-title":"Exploring the gut microbiota: lifestyle choices, disease associations, and personal genomics","author":"Pedroza Matute","year":"2023","journal-title":"Front. Nutr"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J. Nutr"},{"key":"B69","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2019","journal-title":"Gut"},{"key":"B70","doi-asserted-by":"publisher","first-page":"650313","DOI":"10.3389\/fphys.2021.650313","article-title":"Use of short-chain fatty acids for the recovery of the intestinal epithelial barrier affected by bacterial toxins","volume":"12","author":"P\u00e9rez-Reytor","year":"2021","journal-title":"Front. Physiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin","volume":"35","author":"Perry","year":"2013","journal-title":"Immunopathol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1600148","DOI":"10.3389\/fnins.2025.1600148","article-title":"Gut dysbiosis as a potential driver of Parkinson's and Alzheimer's disease pathogenesis","volume":"19","author":"Pfaffinger","year":"2025","journal-title":"Front. Neurosci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: one century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/biomedicines13081831","article-title":"Gut-brain axis in mood disorders: a narrative review of neurobiological insights and probiotic interventions","volume":"13","author":"Rosas-S\u00e1nchez","year":"2025","journal-title":"Biomedicines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","article-title":"Gut microbiome and Parkinson's disease: perspective on pathogenesis and treatment. J. Adv","volume":"50","author":"Salim","year":"2023","journal-title":"Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.chom.2015.04.011","article-title":"Control of brain development, function, and behavior by the microbiome","volume":"17","author":"Sampson","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B80","doi-asserted-by":"publisher","first-page":"986127","DOI":"10.3389\/fnagi.2022.986127","article-title":"Effects of a probiotic suspension SymproveTM on a rat early-stage Parkinson's disease model","volume":"14","author":"Sancandi","year":"2023","journal-title":"Front. Aging Neurosci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41575-025-01077-5","article-title":"The gut microbiome connects nutrition and human health","volume":"22","author":"Sanz","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"102494","DOI":"10.1016\/j.mib.2024.102494","article-title":"Host\u2013microbe interactions: communication in the microbiota\u2013gut-brain axis","volume":"80","author":"Shekarabi","year":"2024","journal-title":"Curr. Opin. Microbiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.3390\/jcm14113673","article-title":"A review of the influence of prebiotics, probiotics, synbiotics, and postbiotics on the human gut microbiome and intestinal integrity","volume":"14","author":"Smolinska","year":"2025","journal-title":"J. Clin. Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain. Behav. Immun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","article-title":"Immune system responses in Parkinson's disease: early and dynamic","volume":"49","author":"Tansey","year":"2019","journal-title":"Eur. J. Neurosci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1113\/JP272134","article-title":"Microglia across the lifespan: from origin to function in brain development, plasticity and cognition","volume":"595","author":"Tay","year":"2017","journal-title":"J. Physiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1126\/science.aat0474","article-title":"Microglia and early brain development: an intimate journey","volume":"362","author":"Thion","year":"","journal-title":"Science"},{"key":"B93","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cell.2017.11.042","article-title":"Microbiome influences prenatal and adult microglia in a sex-specific manner","volume":"172","author":"Thion","year":"","journal-title":"Cell"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"9368","DOI":"10.1039\/D4FO02039A","article-title":"Supplementation with Bifidobacterium animalis subsp. lactis MH-022 for remission of motor impairments in a 6-OHDA-induced Parkinson's disease rat model by reducing inflammation, reshaping the gut microbiome, and fostering specific microbial taxa","volume":"15","author":"Tsao","year":"2024","journal-title":"Food Funct."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/ana.24531","article-title":"Does vagotomy reduce the risk of Parkinson's disease?","volume":"78","author":"Tysnes","year":"2015","journal-title":"Ann. Neurol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","article-title":"Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats","volume":"138","author":"Van Den Berge","year":"2019","journal-title":"Acta Neuropathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain. Behav. Immun"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.010","article-title":"Dynamic structural remodelling of microglia in health and disease: a review of the models, the signals and the mechanisms","volume":"37","author":"Walker","year":"2014","journal-title":"Brain. Behav. Immun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Dig. Dis. Sci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.3389\/fimmu.2018.02325","article-title":"The gut-microglia connection: implications for central nervous system diseases","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","author":"Woodburn","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1567445","DOI":"10.3389\/fnins.2025.1567445","article-title":"The interplay between \u03b1-synuclein aggregation and necroptosis in Parkinson's disease: a spatiotemporal perspective","volume":"19","author":"Xiang","year":"2025","journal-title":"Front. Neurosci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/WNR.0000000000001961","article-title":"Inhibition of the TLR4\/NF-\u03baB pathway promotes the polarization of LPS-induced BV2 microglia toward the M2 phenotype","volume":"34","author":"Xie","year":"2023","journal-title":"NeuroReport"},{"key":"B105","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1039\/D3FO00728F","article-title":"Effect of Lacticaseibacillus paracasei strain Shirota supplementation on clinical responses and gut microbiome in Parkinson's disease","volume":"14","author":"Yang","year":"2023","journal-title":"Food Funct"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00213-024-06606-9","article-title":"Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson's disease: a randomized controlled clinical trial","volume":"241","author":"Zali","year":"2024","journal-title":"Psychopharmacology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41398-020-00878-3","article-title":"A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration. Transl","volume":"10","author":"Zhang","year":"2020","journal-title":"Psychiatry"},{"key":"B108","doi-asserted-by":"publisher","first-page":"961817","DOI":"10.3389\/fphar.2022.961817","article-title":"LPS activates neuroinflammatory pathways to induce depression in Parkinson's disease-like condition","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1529958","DOI":"10.3389\/fimmu.2025.1529958","article-title":"The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fcimb.2017.00318","article-title":"Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus","volume":"7","author":"Zhao","year":"2017","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.2147\/IJGM.S499406","article-title":"Effects of probiotics on neurodegenerative disease-related symptoms and systemic inflammation: a systematic review","volume":"17","author":"Zhu","year":"2024","journal-title":"Int. J. Gen. Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"937555","DOI":"10.3389\/fimmu.2022.937555","article-title":"Gut microbiota: a novel therapeutic target for Parkinson's disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol"}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2025.1690507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:27:51Z","timestamp":1759987671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2025.1690507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":112,"alternative-id":["10.3389\/fnmol.2025.1690507"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2025.1690507","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"article-number":"1690507"}}